Log In Sign up
The largest database of trusted experimental protocols
Protocol detail

Antibodies for Flow Cytometric Analysis of PD-1 Expression

Protocol full text hidden due to copyright restrictions

However, the full text is available at the following link: Access Free Full Text.

Yao W., Zhao X., Gong Y., Zhang M., Zhang L., Wu Q., Wu L., Fan Z., Yan X, & Jiao S. (2021). Impact of the combined timing of PD-1/PD-L1 inhibitors and chemotherapy on the outcomes in patients with refractory lung cancer. ESMO Open, 6(2), 100094.
Publication 2021
Pembrolizumab CellTiter-Glo Luminescent Cell Viability Assay reagent Cisplatin pemetrexed etoposide
Albumin bound paclitaxel Anti cd3 Antibodies Assay Cell viability Cisplatin Cytotoxicity Dicycloplatin Docetaxel Etoposide Fitc Flow cytometric Human Human pd l1 proteins Isotype Luminescent assay Mouse Pembrolizumab Pharmaceutical Promega Sino

Protocol comparator
Top 5 similar protocols

Sign up for free or view similar protocols

Variable analysis

Dependent Variables detection not available due to copyright restrictions.
Unable to provide accurate variables.

Annotations

Annotations not available due to copyright restrictions

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!